Lyvgen Biopharma

Lyvgen Biopharma is a company developing cancer immunotherapy drugs. The company is creating antibodies including PD-1 antibody SSI-361 and a set of proprietary co-stimulation agonist antibodies for cancer treatment. It aims to create drugs targeted to cure such diseases as tumors.